• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tag7-Mts1复合物通过CCR5和CXCR3受体诱导淋巴细胞迁移。

Tag7-Mts1 Complex Induces Lymphocytes Migration via CCR5 and CXCR3 Receptors.

作者信息

Sharapova T N, Romanova E A, Sashchenko L P, Yashin D V

机构信息

Institute of Gene Biology of the Russian Academy of Sciences, Vavilova Str., 34/5, Moscow, 119334 , Russia.

出版信息

Acta Naturae. 2018 Oct-Dec;10(4):115-120.

PMID:30713770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6351033/
Abstract

The discovery of new chemokines that induce the migration of lymphocytes to the infection site is important for the targeted search for therapeutic agents in immunotherapy. We recently showed that Tag7 (PGLYRP1), an innate immunity protein, forms a stable complex with the Ca -binding protein Mts1 (S100A4), which is able to induce lymphocyte movement, although the individual Tag7 and Mts1 do not have this activity. The purpose of this study is to identify receptors that induce the migration of lymphocytes along the concentration gradient of the Tag7-Mts1 complex, and the components of this complex capable of interacting with these receptors. The study investigated the migration of human PBMC under the action of the Tag7-Mts1complex. PBMC of healthy donors were isolated using a standard Ficoll-Hypaque gradient centrifugation procedure. It has been established that the movement of PBMC along the concentration gradient of the Tag7-Mts1 complex is induced by the classical chemotactic receptors CCR5 and CXCR3. It has been shown that only Mts1 is able to bind to the extracellular domain of CCR5, however, this binding is not enough to induce cell movement. A comparative analysis of the primary and 3D structures of the three proteins revealed the homology of the amino acid sequence fragments of the Tag7-Mts1 protein complex with different sites of the CCR5 receptor ligand - MIP1α protein. In conclusion, it should be noted that the Tag7-Mts1 complex can be considered as a new ligand of the classical chemotactic receptors CCR5 and CXCR3.

摘要

发现能够诱导淋巴细胞迁移至感染部位的新型趋化因子,对于在免疫疗法中靶向寻找治疗药物至关重要。我们最近发现,固有免疫蛋白Tag7(PGLYRP1)与钙结合蛋白Mts1(S100A4)形成稳定复合物,该复合物能够诱导淋巴细胞移动,尽管单独的Tag7和Mts1不具备此活性。本研究的目的是鉴定能够沿着Tag7-Mts1复合物浓度梯度诱导淋巴细胞迁移的受体,以及该复合物中能够与这些受体相互作用的成分。该研究调查了Tag7-Mts1复合物作用下人外周血单核细胞(PBMC)的迁移情况。采用标准的Ficoll-Hypaque梯度离心法分离健康供体的PBMC。已证实,PBMC沿着Tag7-Mts1复合物浓度梯度的移动是由经典趋化受体CCR5和CXCR3诱导的。已表明只有Mts1能够与CCR5的胞外结构域结合,然而,这种结合不足以诱导细胞移动。对这三种蛋白质的一级结构和三维结构进行比较分析,揭示了Tag7-Mts1蛋白复合物的氨基酸序列片段与CCR5受体配体-MIP1α蛋白不同位点的同源性。总之,应当指出,Tag7-Mts1复合物可被视为经典趋化受体CCR5和CXCR3的新配体。

相似文献

1
Tag7-Mts1 Complex Induces Lymphocytes Migration via CCR5 and CXCR3 Receptors.Tag7-Mts1复合物通过CCR5和CXCR3受体诱导淋巴细胞迁移。
Acta Naturae. 2018 Oct-Dec;10(4):115-120.
2
A new role for PGRP-S (Tag7) in immune defense: lymphocyte migration is induced by a chemoattractant complex of Tag7 with Mts1.肽聚糖识别蛋白-S(Tag7)在免疫防御中的新作用:Tag7与Mts1的趋化因子复合物可诱导淋巴细胞迁移。
Cell Cycle. 2015;14(22):3635-43. doi: 10.1080/15384101.2015.1104440.
3
Opposite roles of metastasin (S100A4) in two potentially tumoricidal mechanisms involving human lymphocyte protein Tag7 and Hsp70.转移抑制因子(S100A4)在涉及人类淋巴细胞蛋白Tag7和热休克蛋白70的两种潜在杀瘤机制中的相反作用。
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13963-7. doi: 10.1073/pnas.0900116106. Epub 2009 Aug 3.
4
Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity.PGLYRP1/Tag7蛋白在固有免疫和获得性免疫中的作用机制
Acta Naturae. 2021 Jan-Mar;13(1):91-101. doi: 10.32607/actanaturae.11102.
5
Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells.先天免疫蛋白 Tag7(PGRP-S)激活淋巴细胞,使其能够通过 Fasl-Fas 依赖性接触杀伤病毒感染的细胞。
IUBMB Life. 2017 Dec;69(12):971-977. doi: 10.1002/iub.1688. Epub 2017 Oct 30.
6
Tag7-Mts1 Complex Activates Chemotaxis of Regulatory T Cells.Tag7-Mts1 复合物激活调节性 T 细胞的趋化作用。
Dokl Biochem Biophys. 2022 Oct;506(1):181-184. doi: 10.1134/S1607672922050064. Epub 2022 Oct 27.
7
Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide.Mts1(S100A4)及其肽与 Tag7(PGLYRP1)肽复合物具有细胞毒性活性。
Int J Mol Sci. 2024 Jun 16;25(12):6633. doi: 10.3390/ijms25126633.
8
Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor.与热休克蛋白70(Hsp70)结合的Tag7(肽聚糖识别蛋白1,PGLYRP1)通过肿瘤坏死因子受体1(TNFR1)在肿瘤细胞中诱导替代性细胞毒性过程。
J Biol Chem. 2015 Aug 28;290(35):21724-31. doi: 10.1074/jbc.M115.639732. Epub 2015 Jul 16.
9
Lymphocytes incubated in the presence of IL-2 lose the capacity for chemotaxis but acquire antitumor activity.在白细胞介素-2存在的情况下培养的淋巴细胞失去趋化能力,但获得抗肿瘤活性。
Dokl Biol Sci. 2017 Jan;472(1):31-33. doi: 10.1134/S0012496617010094. Epub 2017 Apr 21.
10
The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.CXCR3和CCR5配体在T淋巴细胞迁移中的相对活性:体内外的协同和不同活性
J Leukoc Biol. 2003 Nov;74(5):791-9. doi: 10.1189/jlb.1102547. Epub 2003 Aug 1.

引用本文的文献

1
Analysis and validation of hub genes for atherosclerosis and AIDS and immune infiltration characteristics based on bioinformatics and machine learning.基于生物信息学和机器学习的动脉粥样硬化与艾滋病核心基因分析、验证及免疫浸润特征研究
Sci Rep. 2025 Apr 10;15(1):12316. doi: 10.1038/s41598-025-96907-6.
2
Single-cell RNA-seq analysis revealed the stemness of a specific cluster of B cells in acute lymphoblastic leukemia progression.单细胞 RNA-seq 分析揭示了急性淋巴细胞白血病进展中特定 B 细胞簇的干性。
PeerJ. 2024 Oct 21;12:e18296. doi: 10.7717/peerj.18296. eCollection 2024.
3
Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma.

本文引用的文献

1
A new role for PGRP-S (Tag7) in immune defense: lymphocyte migration is induced by a chemoattractant complex of Tag7 with Mts1.肽聚糖识别蛋白-S(Tag7)在免疫防御中的新作用:Tag7与Mts1的趋化因子复合物可诱导淋巴细胞迁移。
Cell Cycle. 2015;14(22):3635-43. doi: 10.1080/15384101.2015.1104440.
2
Chemokines and immunity.趋化因子与免疫
Einstein (Sao Paulo). 2015 Jul-Sep;13(3):469-73. doi: 10.1590/S1679-45082015RB3438.
3
Tag7 (PGLYRP1) in Complex with Hsp70 Induces Alternative Cytotoxic Processes in Tumor Cells via TNFR1 Receptor.
人类肝内胆管癌图谱中的免疫抑制与表型可塑性
Hepatobiliary Surg Nutr. 2024 Aug 1;13(4):586-603. doi: 10.21037/hbsn-23-400. Epub 2024 Jan 12.
4
Programmed Cell Death-Related Gene Signature Associated with Prognosis and Immune Infiltration and the Roles of HMOX1 in the Proliferation and Apoptosis were Investigated in Uveal Melanoma.探讨了与葡萄膜黑色素瘤预后和免疫浸润相关的程序性细胞死亡相关基因特征,以及 HMOX1 在增殖和凋亡中的作用。
Genes Genomics. 2024 Jul;46(7):785-801. doi: 10.1007/s13258-024-01521-x. Epub 2024 May 20.
5
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.髓系细胞干扰素反应与 SARS-CoV-2 清除相关。
Nat Commun. 2022 Feb 3;13(1):679. doi: 10.1038/s41467-022-28315-7.
6
Myeloid cell interferon responses correlate with clearance of SARS-CoV-2.髓样细胞干扰素反应与新冠病毒清除相关。
Res Sq. 2021 Jul 15:rs.3.rs-664507. doi: 10.21203/rs.3.rs-664507/v1.
7
Mechanisms of Action of the PGLYRP1/Tag7 Protein in Innate and Acquired Immunity.PGLYRP1/Tag7蛋白在固有免疫和获得性免疫中的作用机制
Acta Naturae. 2021 Jan-Mar;13(1):91-101. doi: 10.32607/actanaturae.11102.
与热休克蛋白70(Hsp70)结合的Tag7(肽聚糖识别蛋白1,PGLYRP1)通过肿瘤坏死因子受体1(TNFR1)在肿瘤细胞中诱导替代性细胞毒性过程。
J Biol Chem. 2015 Aug 28;290(35):21724-31. doi: 10.1074/jbc.M115.639732. Epub 2015 Jul 16.
4
Chemokines, their receptors and human disease: the good, the bad and the itchy.趋化因子、其受体与人类疾病:有益的、有害的及引发瘙痒的因素
Immunol Cell Biol. 2015 Apr;93(4):364-71. doi: 10.1038/icb.2015.23.
5
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.国际基础和临床药理学联合会。[更正]。LXXXIX. 趋化因子受体大家族的更新及为非典型趋化因子受体引入新的命名法。
Pharmacol Rev. 2013 Nov 11;66(1):1-79. doi: 10.1124/pr.113.007724. Print 2014.
6
Gradient sensing during chemotaxis.趋化性过程中的梯度感应。
Curr Opin Cell Biol. 2013 Oct;25(5):532-7. doi: 10.1016/j.ceb.2013.06.007. Epub 2013 Jul 20.
7
CCR5 as a potential target in cancer therapy: inhibition or stimulation?CCR5 作为癌症治疗的潜在靶点:抑制还是刺激?
Anticancer Agents Med Chem. 2012 Nov;12(9):1045-57. doi: 10.2174/187152012803529637.
8
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme.MIP-1 趋化因子(CCL3 和 CCL4)的聚合和胰岛素降解酶对 MIP-1 的清除。
EMBO J. 2010 Dec 1;29(23):3952-66. doi: 10.1038/emboj.2010.256. Epub 2010 Oct 19.
9
Opposite roles of metastasin (S100A4) in two potentially tumoricidal mechanisms involving human lymphocyte protein Tag7 and Hsp70.转移抑制因子(S100A4)在涉及人类淋巴细胞蛋白Tag7和热休克蛋白70的两种潜在杀瘤机制中的相反作用。
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13963-7. doi: 10.1073/pnas.0900116106. Epub 2009 Aug 3.
10
Crystal structure of the Ca(2+)-form and Ca(2+)-binding kinetics of metastasis-associated protein, S100A4.转移相关蛋白S100A4的钙离子结合形式的晶体结构及钙离子结合动力学
FEBS Lett. 2008 May 28;582(12):1651-6. doi: 10.1016/j.febslet.2008.04.017. Epub 2008 Apr 22.